- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07532057
Pulmonary Rehabilitation During Chemotherapy in Stage IIIB/IV Small Cell Lung Cancer
Pulmonary Rehabilitation During Chemotherapy in Stage IIIB/IV Small Cell Lung Cancer: A Randomized Controlled Trial
This single-center, parallel-group randomized trial evaluated whether adding an 8-week physiotherapist-supervised pulmonary rehabilitation program to a home program improved functional exercise capacity, pulmonary function, and lung cancer symptoms in adults with stage IIIB/IV small cell lung cancer receiving chemotherapy. Thirty participants were randomized 1:1 to 9 scheduled face-to-face rehabilitation contacts plus twice-daily home exercise and comfortable-pace walking for 20 minutes per day, or to a home program of breathing exercises, coughing or huffing, and comfortable-pace walking for 20 minutes per day without face-to-face rehabilitation. Outcomes were assessed at baseline and after 8 weeks. The principal functional outcome for this report was change in 6-minute walk distance; spirometry and the 9-domain Lung Cancer Symptom Scale were exploratory outcomes.
Studieöversikt
Status
Detaljerad beskrivning
BACKGROUND: Patients with stage IIIB/IV small cell lung cancer receiving chemotherapy can experience deterioration in pulmonary function, exercise capacity, symptoms, and quality of life. Evidence for pulmonary rehabilitation during active chemotherapy remains limited.
STUDY DESIGN: Single-center, parallel-group, open-label randomized controlled trial conducted from November 2018 through May 2019.
SETTING: Oncology Department, Yeditepe University Hospital, Istanbul, Turkey.
ETHICS AND REGISTRATION: The Haliç University Ethics Committee approved the study (No. 109; October 30, 2018), and all participants provided written informed consent before enrollment. The trial was retrospectively registered on April 15, 2026.
PARTICIPANTS: Adults aged 18 years or older with stage IIIB/IV small cell lung cancer, Eastern Cooperative Oncology Group performance status 0-2, active chemotherapy, and no more than 3 completed chemotherapy cycles at enrollment. Participants had to understand the intervention instructions and provide written informed consent. Patients with stage I/II disease or a complication contraindicating pulmonary rehabilitation were excluded.
INTERVENTION GROUP: Nine scheduled face-to-face, physiotherapist-supervised contacts across 8 weeks were used to teach and monitor diaphragmatic and thoracic expansion exercises; postural drainage with percussion when indicated; active-cycle breathing, huffing, and effective coughing; upper- and lower-limb resistance exercises; and walking. The home program was prescribed twice daily, with comfortable-pace walking for 20 minutes per day.
CONTROL GROUP: An 8-week home program of diaphragmatic and thoracic breathing exercises, coughing or huffing, and comfortable-pace walking for 20 minutes per day. The control program did not include face-to-face pulmonary rehabilitation, resistance training, postural drainage or percussion, or active-cycle breathing.
OUTCOMES: Change in 6-minute walk distance from baseline to 8 weeks was designated the principal functional outcome for this report. Exploratory outcomes were forced vital capacity, forced expiratory volume in 1 second, FEV1/FVC, peak expiratory flow, forced expiratory flow at 25%-75% of forced vital capacity, and the 9-domain Lung Cancer Symptom Scale, assessed at baseline and after 8 weeks. No prospectively documented primary-secondary outcome hierarchy was located in the available source records.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Istanbul, Turkiet (Türkiye)
- Yeditepe University Hospital, Oncology Department
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Histologically confirmed small cell lung cancer, Stage IIIB or Stage IV
- Age 18 years or older
- Receiving active chemotherapy with no more than 3 completed chemotherapy cycles at enrollment
- Eastern Cooperative Oncology Group Performance Status 0, 1, or 2
- Able to understand the intervention instructions
- Written informed consent provided
Exclusion Criteria:
- Stage I or Stage II small cell lung cancer
- Any complication contraindicating pulmonary rehabilitation, including a pathological fracture, open wound, unstable cardiac disease, or active uncontrolled infection
- Inability or refusal to provide written informed consent
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Supervised Pulmonary Rehabilitation Plus Home Program
Eight-week program with 9 scheduled face-to-face, physiotherapist-supervised contacts. The contacts were used to teach and monitor diaphragmatic and thoracic expansion exercises; postural drainage with percussion when indicated; active-cycle breathing, huffing, and effective coughing; upper- and lower-limb resistance exercises; and walking. The prescribed home program was performed twice daily, with comfortable-pace walking for 20 minutes per day. |
Eight-week program with 9 scheduled face-to-face, physiotherapist-supervised contacts. The contacts were used to teach and monitor diaphragmatic and thoracic expansion exercises; postural drainage with percussion when indicated; active-cycle breathing, huffing, and effective coughing; upper- and lower-limb resistance exercises; and walking. The prescribed home program was performed twice daily, with comfortable-pace walking for 20 minutes per day. |
|
Aktiv komparator: Home Breathing, Coughing, and Walking Program
Eight-week home program consisting of diaphragmatic and thoracic breathing exercises, effective coughing or huffing, and comfortable-pace walking for 20 minutes per day. No face-to-face pulmonary rehabilitation, resistance training, postural drainage/percussion, or active-cycle breathing was provided. |
Eight-week home program consisting of diaphragmatic and thoracic breathing exercises, effective coughing or huffing, and comfortable-pace walking for 20 minutes per day. No face-to-face pulmonary rehabilitation, resistance training, postural drainage/percussion, or active-cycle breathing was provided. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in 6-Minute Walk Test Distance
Tidsram: Baseline and Week 8
|
Functional exercise capacity measured as the distance walked in a 30-meter indoor corridor. Change is calculated as the Week 8 value minus the baseline value and is reported in meters. |
Baseline and Week 8
|
Andra resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Peak Expiratory Flow
Tidsram: Baseline and Week 8
|
Peak expiratory flow measured by spirometry. Change is calculated as Week 8 minus baseline and is reported in liters per second. |
Baseline and Week 8
|
|
Change in FEV1/FVC Ratio
Tidsram: Baseline and Week 8
|
FEV1/FVC ratio measured by spirometry. Change is calculated as Week 8 minus baseline and is reported in percentage points. |
Baseline and Week 8
|
|
Change in Lung Cancer Symptom Scale Domain Scores
Tidsram: Baseline and Week 8
|
Nine Lung Cancer Symptom Scale visual analog domains were assessed: appetite, fatigue, cough, dyspnea, hemoptysis, pain, overall lung symptom burden, activities of daily living, and overall quality of life. Scores were recorded on 100-mm visual analog scales and reported on a 0-10 cm scale; lower scores indicate better status. Change is calculated as Week 8 minus baseline, so negative values indicate improvement. |
Baseline and Week 8
|
|
Change in Forced Expiratory Volume in 1 Second
Tidsram: Baseline and Week 8
|
Forced expiratory volume in 1 second measured by spirometry. Change is calculated as Week 8 minus baseline and is reported in liters. |
Baseline and Week 8
|
|
Change in Forced Vital Capacity
Tidsram: Baseline and Week 8
|
Forced vital capacity measured by spirometry. Change is calculated as Week 8 minus baseline and is reported in liters. |
Baseline and Week 8
|
|
Change in Forced Expiratory Flow at 25%-75% of Forced Vital Capacity
Tidsram: Baseline and Week 8
|
Forced expiratory flow at 25%-75% of forced vital capacity measured by spirometry. Change is calculated as Week 8 minus baseline and is reported in liters per second. |
Baseline and Week 8
|
Samarbetspartners och utredare
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- HALIC-EC-109-2018
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
A de-identified analytic dataset, data dictionary, and reproducible statistical code may be made available by the corresponding author on reasonable request, subject to ethics, institutional, and consent constraints.
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .